First-in-man study of CPX-351 : a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570291226223316992
  • NII Article ID
    10031042743
  • Data Source
    • CiNii Articles

Report a problem

Back to top